Pharm-Olam announces the appointment of David Murcar to the position of Director, Proposals and Contracts.
AUGUST 17, 2016
Pharm-Olam International Ltd., a multinational, full-service Clinical Research Organization (CRO), serving the biopharmaceutical and medical device industries, announces the appointment of David Murcar to the position of Director, Proposals and Contracts.
“We have been expanding and adding talent to our Proposals and Contracts team in an effort to ensure that we offer our clients strategic proposals that align with their projects’ unique requirements.” said Sanjiv Suri, Pharm-Olam’s Chief Executive Officer. Suri added, “David brings over 20 years of impressive experience to our Client Services team and his leadership allows our entire team to leverage his skills and expertise to focus on the relationships with and the needs of our valued customers, both new and existing.”
Pharm-Olam operates in more than 60 countries worldwide, offering end-to-end clinical trial support for Phase I-IV clinical trials. More information about Pharm-Olam and its full-service capabilities and offerings are available at www.pharm-olam.com or contact us via email at email@example.com (link sends e-mail).
About Pharm-Olam International Group
Pharm-Olam International is a multinational Contract Research Organization (CRO) offering comprehensive clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines, making clinical research as Easy As I, II, III, IV™. For further information about Pharm-Olam, please visit www.pharm-olam.com.